| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |